Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical and biotechnology industries, has augmented its capabilities for pharmacokinetics (PK), immunogenicity, and biomarker testing through the addition of the Gyros Gyrolab xPS workstation. The new Gyrolab xPS allows the company to automate nanoliter-scale immunoassays to support both pre-clinical and clinical studies. “As our clients continue to turn to us for our expertise in evaluating and validating PK and bi...